Litigation: SEC Charges New Jersey Resident With Insider Trading in His Company's Securities
October 18, 2024
October 18, 2024
WASHINGTON, Oct. 18 -- The Securities and Exchange Commission issued the following litigation release (No. 2:24-cv-09801; D.N.J. filed Oct. 15, 2024) involving Ruimin Xie:
* * *
The Securities and Exchange Commission today filed charges against Ruimin Xie, a resident of New Jersey, for insider trading in advance of the April 18, 2023 announcement that BELLUS Health Inc. would be acquired by GSK plc.
The SEC's complaint alleges that, between April 9 and 11, . . .
* * *
The Securities and Exchange Commission today filed charges against Ruimin Xie, a resident of New Jersey, for insider trading in advance of the April 18, 2023 announcement that BELLUS Health Inc. would be acquired by GSK plc.
The SEC's complaint alleges that, between April 9 and 11, . . .